Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018 2019 2020

Details for Mechanism ID: 18484
Country/Region: South Africa
Year: 2018
Main Partner: Aurum Institute
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $52,366,878 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $5,503,313
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $5,829,771
Care: Pediatric Care and Support (PDCS) $2,521,323
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $1,115,461
Health Systems Strengthening (OHSS) $550,000
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $2,639,727
Testing: HIV Testing and Counseling (HVCT) $6,563,059
Sexual Prevention: Other Sexual Prevention (HVOP) $4,453,555
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $720,606
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $19,516,377
Treatment: Pediatric Treatment (PDTX) $2,953,686
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2019 900
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2019 600
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2019 1,500
GEND_GBV Number of people receiving post-GBV care 2019 1,500
HTS_SELF 2019 60,000
HTS_SELF 15-19, Female, Unassisted 2019 2,400
HTS_SELF 15-19, Male, Unassisted 2019 1,200
HTS_SELF 20-24, Female, Unassisted 2019 4,200
HTS_SELF 20-24, Male, Unassisted 2019 1,985
HTS_SELF 25-29, Female, Unassisted 2019 3,960
HTS_SELF 25-29, Male, Unassisted 2019 3,300
HTS_SELF 30-34, Female, Unassisted 2019 4,620
HTS_SELF 30-34, Male, Unassisted 2019 5,459
HTS_SELF 35-39, Female, Unassisted 2019 4,440
HTS_SELF 35-39, Male, Unassisted 2019 7,559
HTS_SELF 40-49, Female, Unassisted 2019 4,200
HTS_SELF 40-49, Male, Unassisted 2019 9,117
HTS_SELF 50+, Female, Unassisted 2019 2,160
HTS_SELF 50+, Male, Unassisted 2019 5,400
HTS_SELF Unassisted 2019 60,000
HTS_SELF Unassisted - Self 2019 60,000
HTS_TST 25-29, Female, Negative 2019 6,085
HTS_TST 25-29, Female, Negative 2019 32,498
HTS_TST 25-29, Female, Negative 2019 830
HTS_TST 25-29, Female, Negative 2019 27,967
HTS_TST 25-29, Female, Negative 2019 214
HTS_TST 25-29, Female, Negative 2019 395
HTS_TST 25-29, Female, Negative 2019 496
HTS_TST 25-29, Female, Negative 2019 11,140
HTS_TST 25-29, Female, Negative 2019 5,757
HTS_TST 25-29, Female, Negative 2019 96
HTS_TST 25-29, Female, Negative 2019 1,713
HTS_TST 25-29, Female, Negative 2019 2,273
HTS_TST 25-29, Female, Negative 2019 9,952
HTS_TST 25-29, Male, Negative 2019 37,751
HTS_TST 25-29, Male, Negative 2019 22,770
HTS_TST 25-29, Male, Negative 2019 1,437
HTS_TST 25-29, Male, Negative 2019 128
HTS_TST 25-29, Male, Negative 2019 258
HTS_TST 25-29, Male, Negative 2019 323
HTS_TST 25-29, Male, Negative 2019 5,826
HTS_TST 25-29, Male, Negative 2019 43
HTS_TST 25-29, Male, Negative 2019 1,547
HTS_TST 25-29, Male, Negative 2019 1,990
HTS_TST 25-29, Male, Negative 2019 10,731
HTS_TST 30-34, Female, Negative 2019 17,249
HTS_TST 30-34, Female, Negative 2019 6,679
HTS_TST 30-34, Female, Negative 2019 50,409
HTS_TST 30-34, Female, Negative 2019 830
HTS_TST 30-34, Female, Negative 2019 17,703
HTS_TST 30-34, Female, Negative 2019 333
HTS_TST 30-34, Female, Negative 2019 610
HTS_TST 30-34, Female, Negative 2019 763
HTS_TST 30-34, Female, Negative 2019 16,384
HTS_TST 30-34, Female, Negative 2019 3,771
HTS_TST 30-34, Female, Negative 2019 155
HTS_TST 30-34, Female, Negative 2019 2,837
HTS_TST 30-34, Female, Negative 2019 3,711
HTS_TST 30-34, Male, Negative 2019 14,506
HTS_TST 30-34, Male, Negative 2019 31,516
HTS_TST 30-34, Male, Negative 2019 53,029
HTS_TST 30-34, Male, Negative 2019 1,078
HTS_TST 30-34, Male, Negative 2019 360
HTS_TST 30-34, Male, Negative 2019 641
HTS_TST 30-34, Male, Negative 2019 772
HTS_TST 30-34, Male, Negative 2019 18,157
HTS_TST 30-34, Male, Negative 2019 169
HTS_TST 30-34, Male, Negative 2019 2,714
HTS_TST 30-34, Male, Negative 2019 3,651
HTS_TST 35-39, Female, Negative 2019 17,454
HTS_TST 35-39, Female, Negative 2019 4,712
HTS_TST 35-39, Female, Negative 2019 52,880
HTS_TST 35-39, Female, Negative 2019 623
HTS_TST 35-39, Female, Negative 2019 9,739
HTS_TST 35-39, Female, Negative 2019 347
HTS_TST 35-39, Female, Negative 2019 642
HTS_TST 35-39, Female, Negative 2019 802
HTS_TST 35-39, Female, Negative 2019 17,444
HTS_TST 35-39, Female, Negative 2019 2,253
HTS_TST 35-39, Female, Negative 2019 169
HTS_TST 35-39, Female, Negative 2019 2,914
HTS_TST 35-39, Female, Negative 2019 3,838
HTS_TST 35-39, Male, Negative 2019 25,791
HTS_TST 35-39, Male, Negative 2019 17,923
HTS_TST 35-39, Male, Negative 2019 58,156
HTS_TST 35-39, Male, Negative 2019 718
HTS_TST 35-39, Male, Negative 2019 362
HTS_TST 35-39, Male, Negative 2019 687
HTS_TST 35-39, Male, Negative 2019 827
HTS_TST 35-39, Male, Negative 2019 15,565
HTS_TST 35-39, Male, Negative 2019 136
HTS_TST 35-39, Male, Negative 2019 3,844
HTS_TST 35-39, Male, Negative 2019 4,938
HTS_TST 40-49, Female, Negative 2019 22,554
HTS_TST 40-49, Female, Negative 2019 4,601
HTS_TST 40-49, Female, Negative 2019 42,119
HTS_TST 40-49, Female, Negative 2019 415
HTS_TST 40-49, Female, Negative 2019 2,899
HTS_TST 40-49, Female, Negative 2019 244
HTS_TST 40-49, Female, Negative 2019 489
HTS_TST 40-49, Female, Negative 2019 611
HTS_TST 40-49, Female, Negative 2019 10,082
HTS_TST 40-49, Female, Negative 2019 548
HTS_TST 40-49, Female, Negative 2019 88
HTS_TST 40-49, Female, Negative 2019 3,064
HTS_TST 40-49, Female, Negative 2019 3,854
HTS_TST 40-49, Male, Negative 2019 58,434
HTS_TST 40-49, Male, Negative 2019 11,429
HTS_TST 40-49, Male, Negative 2019 85,212
HTS_TST 40-49, Male, Negative 2019 471
HTS_TST 40-49, Male, Negative 2019 960
HTS_TST 40-49, Male, Negative 2019 1,172
HTS_TST 40-49, Male, Negative 2019 13,634
HTS_TST 40-49, Male, Negative 2019 107
HTS_TST 40-49, Male, Negative 2019 7,437
HTS_TST 40-49, Male, Negative 2019 9,190
HTS_TST By Key Population: MSM, Negative 2019 15,553
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 255,632
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 1,564,247
HTS_TST Service Delivery Point (Community) Index Mod: 1-9, Negative 2019 3,394
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2019 874
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2019 874
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2019 4,641
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2019 1,967
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2019 5,347
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2019 36,082
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2019 3,785
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2019 5,603
HTS_TST Service Delivery Point (Community) Mobile Testing: 10-14, Female, Negative 2019 2,912
HTS_TST Service Delivery Point (Community) Mobile Testing: 10-14, Male, Negative 2019 947
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2019 11,211
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2019 5,849
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2019 40,973
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2019 8,532
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2019 5,893
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2019 13,092
HTS_TST Service Delivery Point (Community) Other: 1-9, Negative 2019 68
HTS_TST Service Delivery Point (Community) Other: 1-9, Negative 2019 808
HTS_TST Service Delivery Point (Community) Other: 10-14, Female, Negative 2019 337
HTS_TST Service Delivery Point (Community) Other: 10-14, Male, Negative 2019 101
HTS_TST Service Delivery Point (Community) Other: 10-14, Male, Negative 2019 1,078
HTS_TST Service Delivery Point (Community) Other: 15-19, Male, Negative 2019 2,515
HTS_TST Service Delivery Point (Community) Other: 20-24, Female, Negative 2019 1,453
HTS_TST Service Delivery Point (Community) Other: 20-24, Male, Negative 2019 1,437
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 762
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 1,137
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 3,566
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 14,903
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2019 80
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2019 232
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 576
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 2,325
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 128
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 542
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 135
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 532
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 169
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 1,572
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 92
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 768
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 672
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 5,676
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 168
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 1,251
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 466
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 1,506
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 749
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 2,837
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 240
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 1,124
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 57
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 264
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 57
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 264
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 214
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 1,970
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 122
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 976
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 780
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 7,158
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 215
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 1,585
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 586
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 2,096
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 894
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 3,882
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 11,438
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 45,681
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 2,689
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 10,758
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 3,678
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 2,689
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 10,758
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 2,669
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 21,384
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 1,536
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 9,767
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 9,504
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 76,731
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 3,447
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 17,975
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 15,204
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 37,257
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 22,372
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 60,973
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 13,789
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 55,825
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2019 103
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2019 270
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2019 20
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2019 25
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2019 20
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2019 25
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 13
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 120
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 7
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 28
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 51
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 460
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 20
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 85
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 142
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 252
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 226
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 422
HTS_TST_POS 25-29, Female, Positive 2019 1,061
HTS_TST_POS 25-29, Female, Positive 2019 4,197
HTS_TST_POS 25-29, Female, Positive 2019 4,274
HTS_TST_POS 25-29, Female, Positive 2019 103
HTS_TST_POS 25-29, Female, Positive 2019 43
HTS_TST_POS 25-29, Female, Positive 2019 1,124
HTS_TST_POS 25-29, Female, Positive 2019 744
HTS_TST_POS 25-29, Female, Positive 2019 486
HTS_TST_POS 25-29, Female, Positive 2019 198
HTS_TST_POS 25-29, Female, Positive 2019 511
HTS_TST_POS 25-29, Male, Positive 2019 544
HTS_TST_POS 25-29, Male, Positive 2019 6,642
HTS_TST_POS 25-29, Male, Positive 2019 3,538
HTS_TST_POS 25-29, Male, Positive 2019 399
HTS_TST_POS 25-29, Male, Positive 2019 71
HTS_TST_POS 25-29, Male, Positive 2019 28
HTS_TST_POS 25-29, Male, Positive 2019 692
HTS_TST_POS 25-29, Male, Positive 2019 463
HTS_TST_POS 25-29, Male, Positive 2019 171
HTS_TST_POS 30-34, Female, Positive 2019 885
HTS_TST_POS 30-34, Female, Positive 2019 1,120
HTS_TST_POS 30-34, Female, Positive 2019 6,788
HTS_TST_POS 30-34, Female, Positive 2019 3,695
HTS_TST_POS 30-34, Female, Positive 2019 147
HTS_TST_POS 30-34, Female, Positive 2019 67
HTS_TST_POS 30-34, Female, Positive 2019 1,705
HTS_TST_POS 30-34, Female, Positive 2019 672
HTS_TST_POS 30-34, Female, Positive 2019 787
HTS_TST_POS 30-34, Female, Positive 2019 322
HTS_TST_POS 30-34, Male, Positive 2019 734
HTS_TST_POS 30-34, Male, Positive 2019 5,561
HTS_TST_POS 30-34, Male, Positive 2019 6,799
HTS_TST_POS 30-34, Male, Positive 2019 298
HTS_TST_POS 30-34, Male, Positive 2019 164
HTS_TST_POS 30-34, Male, Positive 2019 67
HTS_TST_POS 30-34, Male, Positive 2019 1,829
HTS_TST_POS 30-34, Male, Positive 2019 766
HTS_TST_POS 30-34, Male, Positive 2019 317
HTS_TST_POS 35-39, Female, Positive 2019 897
HTS_TST_POS 35-39, Female, Positive 2019 832
HTS_TST_POS 35-39, Female, Positive 2019 7,037
HTS_TST_POS 35-39, Female, Positive 2019 1,992
HTS_TST_POS 35-39, Female, Positive 2019 156
HTS_TST_POS 35-39, Female, Positive 2019 70
HTS_TST_POS 35-39, Female, Positive 2019 1,802
HTS_TST_POS 35-39, Female, Positive 2019 381
HTS_TST_POS 35-39, Female, Positive 2019 817
HTS_TST_POS 35-39, Female, Positive 2019 333
HTS_TST_POS 35-39, Male, Positive 2019 1,309
HTS_TST_POS 35-39, Male, Positive 2019 3,163
HTS_TST_POS 35-39, Male, Positive 2019 8,820
HTS_TST_POS 35-39, Male, Positive 2019 200
HTS_TST_POS 35-39, Male, Positive 2019 175
HTS_TST_POS 35-39, Male, Positive 2019 72
HTS_TST_POS 35-39, Male, Positive 2019 1,801
HTS_TST_POS 35-39, Male, Positive 2019 1,069
HTS_TST_POS 35-39, Male, Positive 2019 430
HTS_TST_POS 40-49, Female, Positive 2019 1,159
HTS_TST_POS 40-49, Female, Positive 2019 809
HTS_TST_POS 40-49, Female, Positive 2019 6,788
HTS_TST_POS 40-49, Female, Positive 2019 401
HTS_TST_POS 40-49, Female, Positive 2019 129
HTS_TST_POS 40-49, Female, Positive 2019 53
HTS_TST_POS 40-49, Female, Positive 2019 1,252
HTS_TST_POS 40-49, Female, Positive 2019 61
HTS_TST_POS 40-49, Female, Positive 2019 843
HTS_TST_POS 40-49, Female, Positive 2019 334
HTS_TST_POS 40-49, Male, Positive 2019 2,967
HTS_TST_POS 40-49, Male, Positive 2019 2,089
HTS_TST_POS 40-49, Male, Positive 2019 15,793
HTS_TST_POS 40-49, Male, Positive 2019 256
HTS_TST_POS 40-49, Male, Positive 2019 103
HTS_TST_POS 40-49, Male, Positive 2019 2,211
HTS_TST_POS 40-49, Male, Positive 2019 2,081
HTS_TST_POS 40-49, Male, Positive 2019 798
HTS_TST_POS By Key Population: MSM, Positive 2019 2,749
HTS_TST_POS Service Delivery Point (Community) Index Mod: 1-9, Positive 2019 79
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Female, Positive 2019 44
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Male, Positive 2019 36
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2019 904
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2019 347
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2019 1,029
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2019 6,413
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Female, Positive 2019 472
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2019 989
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 10-14, Female, Positive 2019 91
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 10-14, Male, Positive 2019 27
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2019 569
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2019 295
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2019 2,072
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2019 429
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Female, Positive 2019 302
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2019 665
HTS_TST_POS Service Delivery Point (Community) Other: 1-9, Positive 2019 2
HTS_TST_POS Service Delivery Point (Community) Other: 1-9, Positive 2019 22
HTS_TST_POS Service Delivery Point (Community) Other: 10-14, Female, Positive 2019 14
HTS_TST_POS Service Delivery Point (Community) Other: 10-14, Female, Positive 2019 174
HTS_TST_POS Service Delivery Point (Community) Other: 10-14, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Community) Other: 10-14, Male, Positive 2019 50
HTS_TST_POS Service Delivery Point (Community) Other: 15-19, Male, Positive 2019 700
HTS_TST_POS Service Delivery Point (Community) Other: 20-24, Male, Positive 2019 399
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 156
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 530
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 574
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 2,905
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2019 7
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2019 79
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 36
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 167
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 14
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 98
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 18
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 85
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 51
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 367
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 25
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 216
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 174
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 1,608
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 44
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 364
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2019 115
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2019 436
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 182
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 788
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 25
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 114
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 14
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 60
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2019 11
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2019 50
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 19
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 170
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 10
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 84
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 68
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 620
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 18
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 136
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 51
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 181
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 77
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 335
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 1,151
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 4,577
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 629
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 2,515
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 522
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 2,067
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 427
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 3,461
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 220
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 1,699
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 1,552
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 12,568
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 448
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 2,805
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2019 1,409
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2019 4,061
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 2,174
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 7,348
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 268
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 1,134
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 19,388
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2019 19,388
PMTCT_ART Already on ART at beginning of current pregnancy 2019 2,957
PMTCT_ART Already on ART at beginning of current pregnancy 2019 14,165
PMTCT_ART New on ART 2019 15,657
PMTCT_ART New on ART 2019 3,148
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 29,822
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 6,105
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 104,999
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 23,014
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 27,460
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 5,609
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 1,443
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 271
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 28,903
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 5,880
PMTCT_EID Sum of Infant Age disaggregates 2019 28,903
PMTCT_EID Sum of Infant Age disaggregates 2019 5,880
PMTCT_STAT 25-29, Female 2019 37,512
PMTCT_STAT 25-29, Female 2019 7,612
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 5,271
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 1,089
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 27,970
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 5,753
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 4,278
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 745
PMTCT_STAT 30-34, Female 2019 26,016
PMTCT_STAT 30-34, Female 2019 5,443
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 4,603
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 981
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 17,702
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 3,773
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 3,697
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 673
PMTCT_STAT 35-39, Female 2019 14,242
PMTCT_STAT 35-39, Female 2019 3,243
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 2,524
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 579
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 9,735
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 2,254
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 1,992
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 373
PMTCT_STAT 40-49, Female 2019 3,802
PMTCT_STAT 40-49, Female 2019 725
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 490
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 81
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 2,899
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 543
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 398
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 60
PMTCT_STAT By Age (Numerator): : 15-19 2019 966
PMTCT_STAT By Age (Numerator): 15-19 2019 2,005
PMTCT_STAT By Age (Numerator): 20-24 2019 21,036
PMTCT_STAT By Age (Numerator): 20-24 2019 4,867
PMTCT_STAT By Age (Numerator): 50+ 2019 392
PMTCT_STAT By Age (Numerator): 50+ 2019 102
PMTCT_STAT By known positives: 15-19 2019 18
PMTCT_STAT By known positives: 20-24 2019 707
PMTCT_STAT By known positives: 50+ 2019 10
PMTCT_STAT By new negatives: 15-19 2019 764
PMTCT_STAT By new negatives: 20-24 2019 3,560
PMTCT_STAT By new negatives: 50+ 2019 80
PMTCT_STAT By new positives: 15-19 2019 156
PMTCT_STAT By new positives: 20-24 2019 569
PMTCT_STAT By new positives: 50+ 2019 8
PMTCT_STAT By Number of known positives: 15-19 2019 332
PMTCT_STAT By Number of known positives: 20-24 2019 3,234
PMTCT_STAT By Number of known positives: 50+ 2019 10
PMTCT_STAT By Number of new negative: 15-19 2019 1,138
PMTCT_STAT By Number of new negative: 20-24 2019 14,903
PMTCT_STAT By Number of new negative: 50+ 2019 230
PMTCT_STAT By Number of new positives: 15-19 2019 530
PMTCT_STAT By Number of new positives: 20-24 2019 2,901
PMTCT_STAT By Number of new positives: 50+ 2019 79
PMTCT_STAT Number of new ANC and L&D clients 2019 106,028
PMTCT_STAT Number of new ANC and L&D clients 2019 23,212
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 104,999
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 23,014
PMTCT_STAT_den 25-29, Female 2019 35,672
PMTCT_STAT_den 25-29, Female 2019 7,088
PMTCT_STAT_den 30-34, Female 2019 25,504
PMTCT_STAT_den 30-34, Female 2019 5,238
PMTCT_STAT_den 35-39, Female 2019 13,951
PMTCT_STAT_den 35-39, Female 2019 3,101
PMTCT_STAT_den 40-49, Female 2019 3,595
PMTCT_STAT_den 40-49, Female 2019 674
PMTCT_STAT_den By Age (Denominator): <15-19 2019 4,134
PMTCT_STAT_den By Age (Denominator): 10-14 2019 10
PMTCT_STAT_den By Age (Denominator): 15-19 2019 1,269
PMTCT_STAT_den By Age (Denominator): 20-24 2019 22,551
PMTCT_STAT_den By Age (Denominator): 20-24 2019 5,699
PMTCT_STAT_den By Age (Denominator): 50+ 2019 621
PMTCT_STAT_den By Age (Denominator): 50+ 2019 133
PP_PREV 25-29, Female 2019 4,124
PP_PREV 25-29, Male 2019 4,124
PP_PREV 30-34, Female 2019 1,767
PP_PREV 30-34, Male 2019 4,124
PP_PREV 35-39, Female 2019 589
PP_PREV 35-39, Male 2019 589
PP_PREV Age/sex: 10-14 Female 2019 7,069
PP_PREV Age/sex: 10-14 Male 2019 2,946
PP_PREV Age/sex: 15-19 Female 2019 17,674
PP_PREV Age/sex: 15-19 Male 2019 8,837
PP_PREV Age/sex: 20-24 Female 2019 5,891
PP_PREV Age/sex: 20-24 Male 2019 1,178
PP_PREV Age/sex: 50+ Female 2019 3
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2019 58,914
PP_PREV Sum of Age/Sex disaggregates 2019 43,598
PrEP_NEW 25-29, Male 2019 596
PrEP_NEW 30-34, Male 2019 596
PrEP_NEW 35-39, Male 2019 447
PrEP_NEW 40-49, Male 2019 298
PrEP_NEW Male 15-19 2019 299
PrEP_NEW Male 20-24 2019 596
PrEP_NEW Male 50+ 2019 149
PrEP_NEW MSM 2019 2,981
PrEP_NEW Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2019 2,981
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 195
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 6
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 5,308
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 364
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 284
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 6
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 6,594
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 540
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 12,381
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 916
TB_PREV By Age/Sex (Numerator): <15, Female 2019 981
TB_PREV By Age/Sex (Numerator): <15, Female 2019 174
TB_PREV By Age/Sex (Numerator): <15, Male 2019 979
TB_PREV By Age/Sex (Numerator): <15, Male 2019 176
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 47,432
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 9,414
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 26,540
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 5,720
TB_PREV IPT, Life-long ART, Already, Positive 2019 7,594
TB_PREV IPT, Life-long ART, Already, Positive 2019 1,554
TB_PREV IPT, Life-long ART, New, Positive 2019 68,369
TB_PREV IPT, Life-long ART, New, Positive 2019 13,954
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 75,960
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 15,512
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 108,518
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 22,155
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 1,397
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 258
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 1,401
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 250
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 67,754
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 13,467
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 37,936
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 8,168
TB_PREV_den IPT, Life-long ART, Already, Positive 2019 10,850
TB_PREV_den IPT, Life-long ART, Already, Positive 2019 2,211
TB_PREV_den IPT, Life-long ART, New, Positive 2019 97,671
TB_PREV_den IPT, Life-long ART, New, Positive 2019 19,945
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 896
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 203
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 6,175
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 2,327
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 786
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 297
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 6,007
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 2,976
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 13,877
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 5,927
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 14,165
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 6,041
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 905
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 250
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 6,250
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 2,368
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 797
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 291
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 6,078
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 3,012
TX_CURR 25-29, Female, Positive 2019 48,537
TX_CURR 25-29, Female, Positive 2019 5,124
TX_CURR 25-29, Male, Positive 2019 20,121
TX_CURR 25-29, Male, Positive 2019 2,093
TX_CURR 30-34, Female, Positive 2019 77,746
TX_CURR 30-34, Female, Positive 2019 8,078
TX_CURR 30-34, Male, Positive 2019 44,042
TX_CURR 30-34, Male, Positive 2019 4,548
TX_CURR 35-39, Female, Positive 2019 80,844
TX_CURR 35-39, Female, Positive 2019 8,393
TX_CURR 35-39, Male, Positive 2019 50,988
TX_CURR 35-39, Male, Positive 2019 5,297
TX_CURR 40-49, Female, Positive 2019 74,807
TX_CURR 40-49, Female, Positive 2019 7,811
TX_CURR 40-49, Male, Positive 2019 80,388
TX_CURR 40-49, Male, Positive 2019 8,427
TX_CURR Age/Sex: <1 2019 1,089
TX_CURR Age/Sex: <1 2019 94
TX_CURR Age/Sex: <1-9 2019 13,403
TX_CURR Age/Sex: 1-9 2019 1,486
TX_CURR Age/Sex: 10-14 Female 2019 10,846
TX_CURR Age/Sex: 10-14 Female 2019 1,195
TX_CURR Age/Sex: 10-14 Male 2019 8,606
TX_CURR Age/Sex: 10-14 Male 2019 949
TX_CURR Age/Sex: 15-19 Female 2019 14,045
TX_CURR Age/Sex: 15-19 Female 2019 1,457
TX_CURR Age/Sex: 15-19 Male 2019 5,878
TX_CURR Age/Sex: 15-19 Male 2019 599
TX_CURR Age/Sex: 20-24 Female 2019 50,391
TX_CURR Age/Sex: 20-24 Female 2019 5,233
TX_CURR Age/Sex: 20-24 Male 2019 10,816
TX_CURR Age/Sex: 20-24 Male 2019 1,118
TX_CURR Age/Sex: 50+ Female 2019 49,020
TX_CURR Age/Sex: 50+ Female 2019 5,062
TX_CURR Age/Sex: 50+ Male 2019 49,707
TX_CURR Age/Sex: 50+ Male 2019 5,118
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 72,085
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 691,274
TX_CURR Sum of age/sex disaggregates 2019 19,923
TX_CURR Sum of Age/Sex disaggregations 2019 2,056
TX_NEW 25-29, Female, Positive 2019 6,249
TX_NEW 25-29, Female, Positive 2019 533
TX_NEW 25-29, Male, Positive 2019 5,634
TX_NEW 25-29, Male, Positive 2019 498
TX_NEW 30-34, Female, Positive 2019 10,346
TX_NEW 30-34, Female, Positive 2019 913
TX_NEW 30-34, Male, Positive 2019 9,379
TX_NEW 30-34, Male, Positive 2019 781
TX_NEW 35-39, Female, Positive 2019 10,672
TX_NEW 35-39, Female, Positive 2019 931
TX_NEW 35-39, Male, Positive 2019 13,648
TX_NEW 35-39, Male, Positive 2019 1,236
TX_NEW 40-49, Female, Positive 2019 11,189
TX_NEW 40-49, Female, Positive 2019 1,050
TX_NEW 40-49, Male, Positive 2019 27,081
TX_NEW 40-49, Male, Positive 2019 2,619
TX_NEW By Age/Sex: <1 2019 1,077
TX_NEW By Age/Sex: <1 2019 125
TX_NEW By Age/Sex: 1-9 2019 4,684
TX_NEW By Age/Sex: 1-9 2019 516
TX_NEW By Age/Sex: 10-14 Female 2019 3,774
TX_NEW By Age/Sex: 10-14 Female 2019 366
TX_NEW By Age/Sex: 10-14 Male 2019 2,256
TX_NEW By Age/Sex: 10-14 Male 2019 302
TX_NEW By Age/Sex: 15-19 Female 2019 5,399
TX_NEW By Age/Sex: 15-19 Female 2019 524
TX_NEW By Age/Sex: 15-19 Male 2019 2,878
TX_NEW By Age/Sex: 15-19 Male 2019 262
TX_NEW By Age/Sex: 20-24 Female 2019 19,693
TX_NEW By Age/Sex: 20-24 Female 2019 1,959
TX_NEW By Age/Sex: 20-24 Male 2019 4,466
TX_NEW By Age/Sex: 20-24 Male 2019 401
TX_NEW By Age/Sex: 50+ Female 2019 5,468
TX_NEW By Age/Sex: 50+ Female 2019 411
TX_NEW By Age/Sex: 50+ Male 2019 9,497
TX_NEW By Age/Sex: 50+ Male 2019 758
TX_NEW MSM 2019 635
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 181,674
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 18,361
TX_NEW Sum of Age/Sex disaggregates 2019 53,431
TX_NEW Sum of Age/Sex disaggregates 2019 4,983
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 585,565
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 128,063
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 8,542
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 3,256
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2019 1,504
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2019 567
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 8,544
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 3,264
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2019 1,504
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2019 567
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 325,601
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 69,476
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2019 57,465
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2019 12,282
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 155,040
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 32,853
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2019 27,365
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2019 5,798
TX_PVLS_den Denominator: Indication: Routine 2019 497,722
TX_PVLS_den Denominator: Indication: Routine 2019 108,850
TX_PVLS_den Denominator: Indication: Targeted 2019 87,834
TX_PVLS_den Denominator: Indication: Targeted 2019 19,208
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 3,366
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 583
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 3,367
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 575
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 73,975
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 14,719
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 41,403
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 8,852
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 122,083
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 24,917
TX_RET Numerator by Status: Pregnant 2019 1,124
TX_RET Numerator by Status: Pregnant 2019 1,934
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 135,652
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 27,686
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 3,743
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 664
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 3,749
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 676
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 82,196
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 16,364
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 46,014
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 9,879
TX_RET_den Denominator by Status: Pregnant 2019 19,911
TX_RET_den Denominator by Status: Pregnant 2019 5,005
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 631,882
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 131,477
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 1,933
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 227
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 1,392
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 149
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2019 88,464
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2019 42,631
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2019 423,600
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2019 204,949
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 368,030
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 72,009
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2019 112,195
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2019 27,908
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 25,274
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 5,261
TX_TB_den Denominator: By Specimen Sent: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 105,177
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 505,506
TX_TB_den Life-long ART, Already, TB Screen - Negative, Positive 2019 145,629
TX_TB_den Life-long ART, Already, TB Screen - Negative, Positive 2019 28,614
TX_TB_den Life-long ART, Already, TB Screen - Positive, Positive 2019 3,905
TX_TB_den Life-long ART, Already, TB Screen - Positive, Positive 2019 836
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 469,652
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 99,068
TX_TB_den Life-long ART, New, TB Screen - Positive, Positive 2019 12,681
TX_TB_den Life-long ART, New, TB Screen - Positive, Positive 2019 2,938
Cross Cutting Budget Categories and Known Amounts Total: $46,825,595
Key Populations: MSM and TG $1,326,728
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Gender: Gender Based Violence (GBV) $900,000
GBV Prevention
Post GBV Care
Gender: Gender Equality $18,300,000
Changing harmful gender norms and promoting positive gender norms
Promoting gender-related policies and laws that increase legal protection
Increase gender-equitable access to income and productive resources, including education
Equity in HIV prevention, care, treatment and support
Adolescent Girls and Young Women (AGYW) $4,044,765
Human Resources for Health $20,450,000
Motor Vehicles: Leased $416,808
Water $150,000
Motor Vehicles: Purchased $1,237,294